CCL2 and central nervous system cancer: We failed to find a significant association between circulating IL‐4 (Figure 4A), IL‐10 (Figure 4B), IL‐12 (Figure 4C), IL‐23 (Figure 4D), and MCP‐1 (Figure 4E) levels and glioma risk.